JFS Wealth Advisors LLC Trims Stake in CVS Health Co. (NYSE:CVS)

JFS Wealth Advisors LLC decreased its position in shares of CVS Health Co. (NYSE:CVS) by 7.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,857 shares of the pharmacy operator’s stock after selling 304 shares during the quarter. JFS Wealth Advisors LLC’s holdings in CVS Health were worth $173,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new position in CVS Health during the 3rd quarter valued at about $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new position in CVS Health in the fourth quarter worth approximately $28,000. Livelsberger Financial Advisory purchased a new stake in CVS Health during the third quarter worth $31,000. Finally, Legacy Investment Solutions LLC purchased a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and increased their target price for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Finally, Royal Bank of Canada decreased their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $70.28.

CVS Health Stock Performance

Shares of CVS stock opened at $65.71 on Tuesday. The stock has a market cap of $82.84 billion, a PE ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The business has a 50-day simple moving average of $51.11 and a 200-day simple moving average of $55.99. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. On average, equities analysts expect that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.